Lexington Provides Q3 Corporate Review
23. Oktober 2018 18:37 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...